F. Paganin (St Pierre, France)
Intrapleural heparin or heparin combined with human recombinant DNAase is not effective in the treatment of empyema in a rabbit model O. Dikensoy, M. J. Na, H. Liao, Z. Zhu, W. Drake, E. O. Donnelly, R. W. Light (Nashville, United States Of America; Gaziantep, Turkey)
| |
Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP) R. C. Read, A. Torres, H. Lode, J. Carlet, J. H. Winter, J. Garau, T. Welte, M. A. Le Berre, J. E. Ambler, S. H. Choudhri, P. Arvis (Sheffield, Dundee, United Kingdom; Barcelona, Spain; Berlin, Hannover, Germany; Paris, Puteaux, France; West Haven, USA)
| |
In-vitro deposition study of a levofloxacin (LEV) solution into a novel human nasal cast model by the PARI VibrENTÔ U. Schuschnig, E. Klopfer, M. Luber, T. Selzer, M. Keller (Munich, Germany)
| |
Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study A. L. Andreu Rodríguez, R. Blanquer Olivas, E. Fernández Fabrellas, F. Sanz, J. Blanquer Olivas, F. Tatay (Valencia, Spain)
| |
Antibiotic prescribing in acute respiratory infections – are we following guidelines? B. Esdaile, R. Reddy, A. Sykes, B. Mann (Middlesex, United Kingdom)
| |
Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired pneumonia (CAP) in PROTEKT years 1–5 (1999–2004) D. Felmingham, A. Vatopoulos (London, United Kingdom; Athens, Greece)
| |
Cost-efficacy analysis of cefixime switch therapy in the treatment of community acquired pneumonia Y. Guo, C. Xie, M. Zeng, J. Huang, Y. Luo (Guangzhou, China)
| |
Pneumonia as the reason for quitting smoking M. Percinkovski, M. Danilovic, S. Krstic, S. Popevic (Belgrade, Serbia And Montenegro)
| |
Prescription of antibiotics for the treatment of community acquired pneumonia in a district general hospital in the UK D. Owen, T. Shiner, C. Hilton, R. Sivakumar, R. Dent (Hertfordshire, United Kingdom)
| |
Promising prophylactic means and methods for prevention of community-acquired pneumonia and respiratory infections among servicemen in Russia K. D. Jogolev, S. D. Zhogolev, P. I. Ogarkov, N. N. Bespalov, B. S. Sukhanov (St Petersburg, Saransk, Russian Federation)
| |
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia F. Sanz, J. Blanquer, M. L. Briones, R. Blanquer, E. Chiner, C. Aguar (Valencia, Spain)
| |
Recognising poor prognosis community-acquired pneumonia in young adults with simple clinical measurements O. V. Fessenko (Moscow, Russian Federation)
| |
Validating CURB-65 score among inpatients with community acquired pneumonia in Pakistan F. F. Zuberi, A. S. Haque, J. A. Khan, M. Islam (Karachi, Pakistan)
| |
Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study S. M. Wafy, A. A. Mohamed (Assiut, Egypt)
| |
The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course T. V. Rubanik, N. L. Shaporova, V. I. Trofimov (Saint-Petersburg, Russian Federation)
| |
Incidence of pneumonia in patients after stroke Z. S. Arsovski, D. V. Dokic, A. A. Arsovska, A. M. Popovski (Skopje, Fyrom)
| |
Predictive factors of in-hospital mortality of patients with community-acquired pneumonia S. Saleiro, V. Braz, A. Oliveira e Silva, S. Pereira, M. Freitas Silva (Porto, Portugal)
| |
Community acquired pneumonia in the elderly: clinical aspects and prognostic factors I. Djordjevic, T. Pejcic, S. Golubovic, M. Radovic, T. Radjenovic-Petkovic, D. Dacic (Nis, Serbia And Montenegro)
| |
Factors influencing in-hospital mortality in community-acquired pneumonia (CAP) N. B. Lazareva, L. S. Dolgenkova, A. A. Igonin, V. V. Arkhipov, A. N. Tsoi (Moscow, Russian Federation)
| |
Atypical bacterial and viral ethiology of community-acquired pneumonia in Chile: a preliminary report M. H. Ruiz, M. A. Martinez, V. R. Luchsinger, E. M. Zunino, L. R. Aguad, P. L. Arce, M. A. Lopez, L. F. Avendano (Santiago, Chile)
| |